Logotype for GPGI Inc

GPGI Inc (GPGI) Q1 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for GPGI Inc

Q1 2026 earnings summary

7 May, 2026

Executive summary

  • CompoSecure achieved record sales and margin expansion, driven by robust demand, operational improvements from the Resolute Operating System (ROS), and new program wins.

  • Husky faced significant market headwinds from oil/resin price volatility, tariffs, and geopolitical disruptions, resulting in order delays, reduced sales, and margin compression.

  • Full-year 2026 guidance was revised downward, reflecting ongoing strength at CompoSecure but caution for Husky due to persistent market challenges.

  • Strategic focus remains on deploying ROS and targeted investments to drive growth and operational efficiency across both businesses.

  • Completed the acquisition of Husky Technologies Limited for $4.98 billion, expanding into injection molding equipment and services markets.

Financial highlights

  • Pro forma adjusted net sales for Q1 2026 were $421.2 million, up 3% year-over-year; CompoSecure net sales reached $130.4 million, up 26%, and Husky net sales were $290.8 million, down 5%.

  • Pro forma adjusted EBITDA was $82.1 million, down 16% year-over-year, with margins at 19.5%, down 430 basis points.

  • CompoSecure adjusted EBITDA was $47.6 million, up 37%, with margins improving by 300 basis points to 36.5%; Husky adjusted EBITDA was $38.2 million, down 40%, with margins eroding by 770 basis points to 13.2%.

  • GPGI Holdings reported a net loss of $235.0 million for Q1 2026, compared to net income of $21.5 million in Q1 2025, with adjusted EBITDA of $85.0 million, up 146% year-over-year.

  • Adjusted free cash flow for Q1 2026 was approximately $29 million; cash and short-term investments totaled $121.6 million as of March 31, 2026.

Outlook and guidance

  • Q2 2026 guidance: net sales of $425–$475 million, adjusted EBITDA of $105–$120 million, and margins of 24.7%–25.3%.

  • FY 2026 guidance: net sales of $1.95–$2.1 billion, adjusted EBITDA of $550–$610 million, and margins of 28.2%–29%; free cash flow expected at $275–$325 million.

  • Leverage anticipated at ~3x by year-end; margin expansion expected in the second half of 2026.

  • Guidance reflects uncertainty from geopolitical instability, customer order delays, and macroeconomic headwinds.

  • Management expects continued integration of Husky and focus on deleveraging the balance sheet.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more